Vancomycin Susceptibility of Oxacillin-Resistant Staphylococcus aureus Isolates Causing Nosocomial Bloodstream Infections
Author(s) -
Sandra Tallent,
Tammy Bischoff,
Michael W. Climo,
Belinda Ostrowsky,
Richard P. Wenzel,
Michael B. Edmond
Publication year - 2002
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.40.6.2249-2250.2002
Subject(s) - vancomycin , microbiology and biotechnology , staphylococcus aureus , bloodstream infection , bacteremia , micrococcaceae , antibiotics , staphylococcal infections , meticillin , drug resistance , biology , medicine , virology , antibacterial agent , bacteria , genetics
Nosocomial oxacillin-resistant Staphylococcus aureus (ORSA) bloodstream isolates were tested to determine the prevalence of vancomycin heteroresistance. We screened 619 ORSA nosocomial bloodstream isolates from 36 hospitals between 1997 and 2000. Only one isolate exhibiting heterotypic resistance was detected. Thus, vancomycin heteroresistance in clinical bloodstream isolates remains rare in the United States.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom